 |
 |
 |
 |
 |
 |
News from SGC
Posted on Tuesday 15th of March 2016
After 12 years, SGC’s pharma partners remain committed to the consortium because, they say, they can reproduce its work. CEO Aled Edwards reflects on the lessons he’s learned from working with industry since the consortium’s inception, and he defines eight principles that when applied in combination to a research program can increase the reliability of the program’s output.
Posted on Thursday 3rd of March 2016
Rachel Harding, a researcher at SGC Toronto, appears on Global News discussing her open science experiment. She's welcomed the world to view her research progress in real-time by placing her lab notes online and explaining her results on her blog Lab Scribbles. Rachel hopes that this will help speed up our understanding of Huntington's disease, a devastating neurodegenerative disorder with no cure and the focus of her research.
Posted on Monday 29th of February 2016
DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced its partnership with the Structural Genomics Consortium (SGC), a public-private organization established in 2003, to develop selective and potent chemical probes for the unexplored human kinome and to promote open sharing of these probes with the scientific community.
Posted on Friday 26th of February 2016
University of Toronto researcher Rachel Harding will be the first known biomedical researcher to welcome the world to review her lab notes in real time.
Posted on Tuesday 16th of February 2016
Podcast: Meet our Researchers
Posted on Tuesday 9th of February 2016
This month, we talk to Dr Wen Hwa Lee, Strategic Alliances Manager at the Structural Genomics Consortium (SGC), part of the Nuffield Department of Clinical Medicine, about how the SGC is revolutionising the way we think about drug discovery.
Posted on Thursday 4th of February 2016
Pan-Canadian Team of Researchers Will Receive CA$11.7 Million in Funding from Stand Up To Cancer Canada, Genome Canada, Canadian Institutes of Health Research, Cancer Stem Cell Consortium, and Ontario Institute for Cancer Research
Posted on Tuesday 26th of January 2016
Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology and chemical proteomics.
Posted on Thursday 21st of January 2016
This SRC is focused on the role of Methylation Dynamics in nuclear and cytoplasmic biological processes and how this modification impacts development, epigenetic cellular identity, tissue homeostasis and disease.
Posted on Tuesday 12th of January 2016
During DPhG Annual Meeting 2015 which took place in Düsseldorf September 23-25, 2015, the German Pharmaceutical Society honoured a few up-and-coming young scientists.
Pages
